Stephen D. Simpson, CFA

  1. Packaging Getting Boxed In
    Stock Analysis

    Packaging Getting Boxed In

    Worries about a cyclical top have knocked the packaging sector.
  2. Cintas Not Scintillating
    Stock Analysis

    Cintas Not Scintillating

    Cintas can do little to boost its core business, and new business expansions seem like odd choices.
  3. FDA To Obesity Drugs: Drop Dead
    Stock Analysis

    FDA To Obesity Drugs: Drop Dead

    An FDA panel knocks down yet another would-be obesity drug.
  4. FedEx Still Loading Up
    Stock Analysis

    FedEx Still Loading Up

    Investors can use conservative guidance to their advantage when good stocks sell off.
  5. The Steel Sector: No Jam Today, But Maybe Tomorrow?
    Stock Analysis

    The Steel Sector: No Jam Today, But Maybe Tomorrow?

    Warnings from the steel sector suggest the economy definitely slowed in the third quarter
  6. Another Big Gulf Clean-Up Operation
    Stock Analysis

    Another Big Gulf Clean-Up Operation

    A new rule regarding the decommissioning of old wells and platforms could be a much-needed boon for services companies.
  7. China's Potash Hypocrisy
    Stock Analysis

    China's Potash Hypocrisy

    China is angry about an untennable potash monopoly, but the country needs to look in the mirror.
  8. Chocolate 2.0
    Stock Analysis

    Chocolate 2.0

    Will modern genomics remodel the candy business into a more productive industry?
  9. Investing Myths That Need To Go
    Fundamental Analysis

    Investing Myths That Need To Go

    Certain investing myths just won't die. Find out how dated sayings could be costing you.
  10. Get Paid To Wait By Paychex
    Stock Analysis

    Get Paid To Wait By Paychex

    With bond-beating yield and a great franchise, Paychex is a name for patient investors to consider.
  11. Allied Irish Banks Tries To Avoid Trouble
    Stock Analysis

    Allied Irish Banks Tries To Avoid Trouble

    Allied Irish needs a healthy operating environment, and that looks to be a ways off.
  12. Lab Corp And Genzyme Find Some Common Ground
    Stock Analysis

    Lab Corp And Genzyme Find Some Common Ground

    Genzyme and Lab Corp. forge a rare win-win deal in the lab space.
  13. Good Luck At Nokia, Elop, You'll Need It
    Stock Analysis

    Good Luck At Nokia, Elop, You'll Need It

    Can a new CEO change Nokia's fortunes?
  14. Market News That Seems Promising - But Isn't
    Investing

    Market News That Seems Promising - But Isn't

    Not all good news is created equal. Find out how some positive stock market news can actually be bad news for investors.
  15. Bristol-Myers Pays A Premium For Its Partner
    Stock Analysis

    Bristol-Myers Pays A Premium For Its Partner

    Bristol-Myers is paying a lot, but a successful HCV franchise could be worth much more.
  16. 4 Companies That Should Have Sold Out
    Stock Analysis

    4 Companies That Should Have Sold Out

    When company management gets unreasonably stubborn and refuses a merger or buyout, shareholders often pay the price.
  17. 4 Companies That Should Have Sold Out
    Personal Finance

    4 Companies That Should Have Sold Out

    When company management gets unreasonably stubborn and refuses a merger or buyout, shareholders often pay the price.
  18. Pfizer's Decision Leaves Celldex Reeling
    Stock Analysis

    Pfizer's Decision Leaves Celldex Reeling

    We'll look at what Pfizer withdraw of support for Celldex's cancer vaccine means for the biotech's stock.
  19. How To Double Your Bets On Financials
    Stock Analysis

    How To Double Your Bets On Financials

    Leverage is powerful, but dangerous as well.
  20. Back To The Future With Ethanol?
    Stock Analysis

    Back To The Future With Ethanol?

    Ethanol prices have some investors once again dreaming of a bright future for this fuel alternative.
  21. Buy Joseph A. Bank, Get A Double Free?
    Stock Analysis

    Buy Joseph A. Bank, Get A Double Free?

    The improvements made by this company are startling, and give patient investors everywhere reason to hope.
  22. UTi Worldwide: Still A Name To Play In Freight
    Stock Analysis

    UTi Worldwide: Still A Name To Play In Freight

    UTIW hasn't enjoyed the same rebound as other transports; savvy investors should ask why.
  23. Waiting For A Rebound In Vanity
    Stock Analysis

    Waiting For A Rebound In Vanity

    Pure-play aesthetics companies have been hit hard by the recession, but does the desire for beauty ever go away for good?
  24. Signs Of Life In Radiation Therapy
    Stock Analysis

    Signs Of Life In Radiation Therapy

    Hospital spending on big-ticket items is recovering and that should be good news for the radiation oncology sector.
  25. Private Equity Has A Hankering For Fast Food
    Stock Analysis

    Private Equity Has A Hankering For Fast Food

    Burger King passes to yet another owner with the hopes of a turnaround.
  26. 4 Stocks For An Uncertain Market
    Stock Analysis

    4 Stocks For An Uncertain Market

    In times of trouble, these names offer additional safety without sacrificing too much upside.
  27. A Primer On Offshore Drilling
    Forex Education

    A Primer On Offshore Drilling

    Learn the important ratios and terms that you'll need to know to get involved in this trading sector.
  28. 5 Warning Signs For Bad PR Stocks
    Personal Finance

    5 Warning Signs For Bad PR Stocks

    Investing in bad news may work when the bad news is trivial, but some matters are too serious to ignore.
  29. Intel Buys Its Way Into Wireless
    Stock Analysis

    Intel Buys Its Way Into Wireless

    Intel announces a much-rumored deal to buy the #4 smartphone wireless chip provider.
  30. Top-Heavy Pharmaceuticals
    Stock Analysis

    Top-Heavy Pharmaceuticals

    Investors should keep an eye on how much drug companies rely on its top sellers.
  31. Can The U.S. Switch To Natural Gas?
    Stock Analysis

    Can The U.S. Switch To Natural Gas?

    Who stands to benefit if the U.S. decides to leverage this cheap and abundant fuel source?
  32. Another Setback For Roche Is Bad News For ImmunoGen
    Stock Analysis

    Another Setback For Roche Is Bad News For ImmunoGen

    Roche suffers another setback to its key cancer franchise, while ImmunoGen faces a major delay in royalty payments.
  33. The Best Business To Be In During A Recovery (And Why)
    Personal Finance

    The Best Business To Be In During A Recovery (And Why)

    Where are the best places to be when an economy starts to recover?
  34. Medtronic Looks A Little Woozy
    Stock Analysis

    Medtronic Looks A Little Woozy

    It seems that the expectations for Medtronic are so low that long-term investors have little to fear.
  35. 3Par Suddenly A Hot Property
    Stock Analysis

    3Par Suddenly A Hot Property

    3Par went nowhere fast during the recession, but this storage company is now the prize in a bidding war.
  36. The 6 Signs Of An Economic Recovery
    Credit & Loans

    The 6 Signs Of An Economic Recovery

    For all the talk of whether the economy is recovering or sinking, what should a recovery actually look like?
  37. The Next-Gen Sequencing Pot Keeps Bubbling
    Stock Analysis

    The Next-Gen Sequencing Pot Keeps Bubbling

    Last week saw two major developments in one of the fastest-growing arenas of life science.
  38. Starting A Business? Consider This First
    Professionals

    Starting A Business? Consider This First

    Going into business for yourself can be a fantastic, liberating experience. But beware of the hidden pitfalls.
  39. How Should Apple Spend Its Money?
    Personal Finance

    How Should Apple Spend Its Money?

    Apple has a small fortune in cash and securities. With so much to spend, Apple could shake up a number of industries.
  40. Agile Agilent
    Stock Analysis

    Agile Agilent

    Agilent may defy easy categorization, but its quality does not depend on labels.
  41. Middleby Stuck In The Middle For Now
    Stock Analysis

    Middleby Stuck In The Middle For Now

    Middleby continues to gain share in a fragmented market.
  42. Payback Time In For-Profit Education
    Stock Analysis

    Payback Time In For-Profit Education

    The government's data on loan repayment rates could mean major changes to a thriving sector.
  43. Advance Auto Parts Continues A Winning Formula
    Stock Analysis

    Advance Auto Parts Continues A Winning Formula

    In a sketchy retail environment, Advance Auto keeps finding paths to profitable growth
  44. CareFusion Looks To Pump Up Returns
    Stock Analysis

    CareFusion Looks To Pump Up Returns

    CareFusion is an oft-overlooked name, but the potential to gain market share in drug pumps could move the stock.
  45. Is The Billionaire Charity Pledge A Good Idea?
    Personal Finance

    Is The Billionaire Charity Pledge A Good Idea?

    Will Bill Gates' call for billionaires to become more active in charitable giving do all the good it could?
  46. A123 Needs To Recharge
    Stock Analysis

    A123 Needs To Recharge

    Earnings don't really matter right now, but the loss of the Chrysler deal could be a warning.
  47. 4 Stocks You Never Should Have Sold
    Personal Finance

    4 Stocks You Never Should Have Sold

    Pullbacks and retracements are just a normal part of a stock's trajectory. Don't let momentary moves chase you out of a good idea.
  48. The Curious Case Of PPCO
    Stock Analysis

    The Curious Case Of PPCO

    Endo's deal for Penwest makes sense, but it seems like there may have been some shennanigans with the stock in the days before the announcement.
  49. Cree Not Burning Out Yet
    Stock Analysis

    Cree Not Burning Out Yet

    Momentum investors seem poised to punish CREE for soft guidance, but the growth is strong.
  50. A Nabor-ly Deal For Superior Well Services
    Stock Analysis

    A Nabor-ly Deal For Superior Well Services

    Nabors takes a large step into the services arena, and a prime buyout target goes away.